Close this search box.
The logo for Emerge Australia, centered around the keyword ME/CFS.
Close this search box.
Close this search box.
Close this search box.

May 2024 International Research and Advocacy Roundup

Our International Roundup provides a brief snapshot of some of the ME/CFS research funding, clinical care and advocacy actions around the world in the last few months. 



  • The 1st International Conference on Clinical and Scientific Advances in ME/CFS and Long COVID took place in Portugal on 3-4 April 2024. Speakers included Dr Susan Levine, Dr David Systrom, Dr Elizabeth Unger, Dr Lucinda Bateman, Dr Luis Nacul and Professor Jonas Bergquist. Recordings of the conference are available:
  • The European ME Alliance (EMEA) released the results of its Pan-European ME Patient Survey. The survey had more than 11,000 respondents with ME/CFS from across Europe.
    Key results:
        – ME /CFS is profoundly disabling
        – Myths persist that ME/CFS “burns out” and people recover over time
        – There are huge unmet healthcare needs
        – Pacing was by far the most helpful strategy
        – Activity-based therapies do more harm than good
        – Early diagnosis and education about pacing are key to preventing disease progression
  • The US National Institutes of Health (NIH) has made the de-identified data of 14,000 people with Long COVID available to authorised researchers through Biodata Catalyst (BDC), a cloud-based system developed by the NIH. It is hoped that access to this data will help accelerate Long COVID research.

Clinical Care



Search our site
Share on Social

Join our Newsletter

Giving a voice to the unseen and unheard. Sign up to our newsletter today.

Scroll to Top